Suppr超能文献

RalA对细胞外死亡途径的mTOR非依赖性翻译控制。

mTOR-independent translational control of the extrinsic cell death pathway by RalA.

作者信息

Panner Amith, Nakamura Jean L, Parsa Andrew T, Rodriguez-Viciana Pablo, Berger Mitchel S, Stokoe David, Pieper Russell O

机构信息

UCSF Cancer Center, 2340 Sutter St., Rm N219, San Francisco, CA 94115-0875, USA.

出版信息

Mol Cell Biol. 2006 Oct;26(20):7345-57. doi: 10.1128/MCB.00126-06. Epub 2006 Aug 7.

Abstract

Oncogenic potential is associated with translational regulation, and the prevailing view is that oncogenes use mTOR-dependent pathways to up-regulate the synthesis of proteins critical for transformation. In this study, we show that RalA, a key mediator of Ras transformation, is also linked to the translational machinery. At least part of this linkage, however, is independent of mTOR and acts through RalBP1 to suppress cdc42-mediated activation of S6 kinase and the translation of the antiapoptotic protein FLIP(S). This action, rather than contributing to transformation, opens a latent tumor-suppressive mechanism that can be activated by tumor necrosis factor-related apoptosis-inducing ligand. These results show that the translational machinery is linked to tumor suppression as well as cell-proliferative pathways and that the reestablishment of cell death pathways by activation of the Ral oncogenic program provides a means for selective therapeutic targeting of Ral-driven malignancies.

摘要

致癌潜能与翻译调控相关,目前普遍的观点是癌基因利用mTOR依赖性途径上调对细胞转化至关重要的蛋白质的合成。在本研究中,我们发现RalA(Ras转化的关键介质)也与翻译机制相关。然而,这种联系至少部分独立于mTOR,并通过RalBP1发挥作用,以抑制cdc42介导的S6激酶激活和抗凋亡蛋白FLIP(S)的翻译。这种作用并非促进细胞转化,而是开启了一种潜在的肿瘤抑制机制,该机制可被肿瘤坏死因子相关凋亡诱导配体激活。这些结果表明,翻译机制与肿瘤抑制以及细胞增殖途径相关,并且通过激活Ral致癌程序重建细胞死亡途径为选择性治疗Ral驱动的恶性肿瘤提供了一种手段。

相似文献

1
mTOR-independent translational control of the extrinsic cell death pathway by RalA.
Mol Cell Biol. 2006 Oct;26(20):7345-57. doi: 10.1128/MCB.00126-06. Epub 2006 Aug 7.
2
mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.
Mol Cell Biol. 2005 Oct;25(20):8809-23. doi: 10.1128/MCB.25.20.8809-8823.2005.
3
Translational regulation of TRAIL sensitivity.
Cell Cycle. 2006 Jan;5(2):147-50. doi: 10.4161/cc.5.2.2359. Epub 2006 Jan 16.
5
Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
Mol Biol Cell. 2013 Jun;24(11):1812-24. doi: 10.1091/mbc.E13-01-0007. Epub 2013 Apr 10.
8
Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.
Mol Cell Biol. 2010 Jan;30(2):508-23. doi: 10.1128/MCB.00916-08. Epub 2009 Nov 9.

引用本文的文献

1
The E3 ubiquitin ligase Itch restricts antigen-driven B cell responses.
J Exp Med. 2019 Sep 2;216(9):2170-2183. doi: 10.1084/jem.20181953. Epub 2019 Jul 16.
2
Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.
J Carcinog Mutagen. 2013;Suppl 6. doi: 10.4172/2157-2518.S6-003.
3
c-FLIP, a master anti-apoptotic regulator.
Exp Oncol. 2012 Oct;34(3):176-84.
4
Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse.
Cancer Biol Ther. 2012 Jun;13(8):694-700. doi: 10.4161/cbt.20087. Epub 2012 Jun 1.
5
Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.
Cancers (Basel). 2011 Jun;3(2):1639-71. doi: 10.3390/cancers3021639.
6
Novel role of c-jun N-terminal kinase in regulating the initiation of cap-dependent translation.
Int J Oncol. 2012 Feb;40(2):577-82. doi: 10.3892/ijo.2011.1252. Epub 2011 Nov 4.
8
RalA function in dermal fibroblasts is required for the progression of squamous cell carcinoma of the skin.
Cancer Res. 2011 Feb 1;71(3):758-67. doi: 10.1158/0008-5472.CAN-10-2756. Epub 2010 Dec 15.
9
A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Cancer Res. 2009 Oct 15;69(20):7911-6. doi: 10.1158/0008-5472.CAN-09-1287. Epub 2009 Oct 6.
10
RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.
Oncogene. 2010 Jan 7;29(1):45-55. doi: 10.1038/onc.2009.307. Epub 2009 Oct 5.

本文引用的文献

1
Role of Cdc42 in neurite outgrowth of PC12 cells and cerebellar granule neurons.
Mol Cell Biochem. 2006 Jan;281(1-2):17-25. doi: 10.1007/s11010-006-0165-9.
2
A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15195-200. doi: 10.1073/pnas.0505114102. Epub 2005 Oct 6.
3
mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells.
Mol Cell Biol. 2005 Oct;25(20):8809-23. doi: 10.1128/MCB.25.20.8809-8823.2005.
4
Translational deregulation in PDK-1-/- embryonic stem cells.
Mol Cell Biol. 2005 Oct;25(19):8465-75. doi: 10.1128/MCB.25.19.8465-8475.2005.
5
An expanding role for mTOR in cancer.
Trends Mol Med. 2005 Aug;11(8):353-61. doi: 10.1016/j.molmed.2005.06.007.
6
Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
Cancer Cell. 2005 Jun;7(6):533-45. doi: 10.1016/j.ccr.2005.04.030.
7
RalGDS is required for tumor formation in a model of skin carcinogenesis.
Cancer Cell. 2005 Mar;7(3):219-26. doi: 10.1016/j.ccr.2005.01.029.
8
RalGDS comes of age.
Cancer Cell. 2005 Mar;7(3):205-6. doi: 10.1016/j.ccr.2005.02.012.
9
RAS, MYC, and sensitivity to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
Cancer Res. 2005 Feb 15;65(4):1615-6; author reply 1616-7. doi: 10.1158/0008-5472.CAN-04-2757.
10
Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells.
Mol Cell Biol. 2005 Mar;25(5):1680-95. doi: 10.1128/MCB.25.5.1680-1695.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验